Cargando…
Antibodies to interleukin 12 abrogate established experimental colitis in mice
In this study, we describe a novel murine model of chronic intestinal inflammation induced by the hapten reagent 2,4,6-trinitrobenzene sulfonic acid (TNBS). Rectal application of low doses of TNBS in BALB/c and SJL/J mice resulted in a chronic transmural colitis with severe diarrhea, weight loss, an...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192205/ https://www.ncbi.nlm.nih.gov/pubmed/7595199 |
Ejemplares similares
-
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
Publicado: (1996) -
Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
por: Horiuchi, Hiroshi, et al.
Publicado: (2021) -
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
Publicado: (1995) -
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis
Publicado: (1995) -
Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7)
por: Wittig, Bianca M., et al.
Publicado: (2000)